Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo

Microbial Pathogenesis

Volumn 29, Issue 4, 2000, Pages 203-212

  Freistadt, M S ^a   Eberle, K E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD155; Monocytes; Pathogenesis; Poliovirus

Indexed keywords

CD155 ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS; RNA VIRUSES;

EID: 0033803694     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.2000.0386     Document Type: Article

References (56)

1. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily
2. The poliovirus receptor protein is produced both as membrane-bound and secreted forms
3. Poliovirus receptor on human blood cells: A possible extraneural site of poliovirus replication
4. Distribution of the poliovirus receptor in human tissue
5. Leucocyte differentiation antigen database
6. Receptor affinities as major determinants of enterovirus tissue tropisms in humans
7. Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues
8. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis
9. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice
10. Poliovirus type 1 enters the human host through intestinal M cells
11. Poliovirus
12. Experimental poliomyelitis following intramuscular virus injection: III. The effect of passive antibody on paralysis and viremia
13. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor
14. Poliovirus spreads from muscle to the central nervous system by neural pathways
15. Mechanism of inquiry-provoked poliomyelitis
16. Entry, dissemination, shedding and transmission of viruses
17. Poliomyelitis: Pathogenesis and histopathology
18. Characterization of mouse lines transgenic with the human poliovirus receptor gene
19. Human-mouse hybrid cell lines and susceptibility to poliovirus. I. Conversion from polio sensitivity to polio resistance accompanying loss of human gene-dependent polio receptors
20. Transformation of a human poliovirus receptor gene into mouse cells
21. Transgenic mice susceptible to poliovirus
22. Human recombinant interleukin-1 beta up-regulates elastin gene expression in dermal fibroblasts. Evidence for transcriptional regulation in vitro and in vivo
23. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice
24. The murine L-plastin gene promoter: Identification and comparison with the human L-plastin gene promoter
25. Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: Transcription factor FKHR binds the insulin response sequence
26. Molecular cloning and characterization of the mouse Ecm1 gene and its 5' regulatory sequences
27. Comparative sequence analysis of the mouse and human transferrin promoters: Hormonal regulation of the transferrin promoter in Sertoli cells
28. The isolation and characterization of the promoter of the human type 1 inositol 1,4,5-trisphosphate receptor
29. Low levels of poliovirus replication in primary human monocytes: Possible interactions with lymphocytes
30. Correlation between poliovirus (Type 1) Mahoney replication in blood cells and neurovirulence
31. F4/80 a monoclonal antibody directed specifically against the mouse macrophage
32. Macrophages and monocytes
33. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
34. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
35. Infection of primary human monocytes by Epstein-Barr virus
36. Comparison of susceptible and resistant cells to infection with poliomyelitis virus
37. Replication of poliovirus in phytohemagglutinin-stimulated human lymphocytes
38. Construction and properties of intertypic poliovirus recombinants: First approximation mapping of the major determinants of neurovirulence
39. Genetic analysis of the attenuation phenotype of poliovirus type 1
40. Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine
41. Identification of two determinants that attenuate vaccine-related type 2 poliovirus
42. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: Possible role in neurotoxicity
43. Inhibition of Japanese encephalitis virus infection by nitric oxide: Antiviral effect of nitric oxide on RNA virus replication
44. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV)
45. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice
46. Role of macrophages during Theiler's virus infection
47. Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys
48. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
49. A model for monocyte migration through the blood-brain barrier during HIV-I encephalitis
50. Specific tropism of HIV-1 for microglial cells in primary human brain cultures
51. NF-kappaB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-gamma-induced nitric oxide production in macrophages
52. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
53. Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene
54. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase
55. Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site